Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR

被引：0

作者：

Reaper, Philip M. ^{[1
]}

Griffiths, Matthew R. ^{[1
]}

Long, Joanna M. ^{[1
]}

Charrier, Jean-Damien ^{[1
]}

MacCormick, Somhairle ^{[1
]}

Charlton, Peter A. ^{[1
]}

Golec, Julian M. C. ^{[1
]}

Pollard, John R. ^{[1
]}

机构：

[1] Vertex Pharmaceut Europe, Abingdon, Oxon, England

来源：

NATURE CHEMICAL BIOLOGY | 2011年 / 7卷 / 07期

关键词：

DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; LUNG-CANCER; CISPLATIN; ACTIVATION; CARCINOMA; CHROMATIN; REPAIR; MODEL; CHK2;

D O I：

10.1038/NCHEMBIO.573

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Here we report a comprehensive biological characterization of a potent and selective small-molecule inhibitor of the DNA damage response (DDR) kinase ATR. We show a profound synthetic lethal interaction between ATR and the ATM-p53 tumor suppressor pathway in cells treated with DNA-damaging agents and establish ATR inhibition as a way to transform the outcome for patients with cancer treated with ionizing radiation or genotoxic drugs.

引用

页码：428 / 430

页数：3

共 50 条

[1] Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
Reaper P.M.
Griffiths M.R.
Long J.M.
Charrier J.-D.
MacCormick S.
Charlton P.A.
Golec J.M.C.
Pollard J.R.
Nature Chemical Biology, 2011, 7 (7) : 428 - 430
[2] Exploring SPK98 for the Selective Sensitization of ATM- or P53-Deficient Cancer Cells
Priya, Bhanu
Dubey, Gurudutt
Kirubakaran, Sivapriya
ACS OMEGA, 2023, 8 (05): : 4954 - 4962
[3] Selective killing of p53-deficient cancer cells by SP600125
Jemaa, Mohamed
Vitale, Ilio
Kepp, Oliver
Berardinelli, Francesco
Galluzzi, Lorenzo
Senovilla, Laura
Marino, Guillermo
Malik, Shoaib Ahmad
Rello-Varona, Santiago
Lissa, Delphine
Antoccia, Antonio
Tailler, Maximilien
Schlemmer, Frederic
Harper, Francis
Pierron, Gerard
Castedo, Maria
Kroemer, Guido
EMBO MOLECULAR MEDICINE, 2012, 4 (06) : 500 - 514
[4] Preferential killing of p53-deficient cancer cells by reversine
Jemaa, Mohamed
Galluzzi, Lorenzo
Kepp, Oliver
Boileve, Alice
Lissa, Delphine
Senovilla, Laura
Harper, Francis
Pierron, Gerard
Berardinelli, Francesco
Antoccia, Antonio
Castedo, Maria
Vitale, Ilio
Kroemer, Guido
CELL CYCLE, 2012, 11 (11) : 2149 - 2158
[5] Self-deleting suicide vectors (SDSV):: Selective killing of p53-deficient cancer cells
Andreú, T
Ebensperger, C
Westphal, EM
Klenner, T
Stewart, AF
Westhof, A
Müller, P
Knaus, R
von Melchner, H
CANCER GENE THERAPY, 2000, 7 (12) : S9 - S10
[6] Self-deleting suicide vectors (SDSV):: Selective killing of p53-deficient cancer cells
Andreú, T
Ebensperger, C
Westphal, EM
Klenner, T
Stewart, AF
Westhof, A
Müller, P
Knaus, R
von Melchner, H
CANCER RESEARCH, 2001, 61 (18) : 6925 - 6930
[7] p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage
Reinhardt, H. Christian
Aslanian, Aaron S.
Lees, Jacqueline A.
Yaffe, Michael B.
CANCER CELL, 2007, 11 (02) : 175 - 189
[8] Combined inhibition of CTPS1 and ATR is a metabolic vulnerability in p53-deficient myeloma cells
Durand, Romane
Bellanger, Celine
Descamps, Geraldine
Dousset, Christelle
Maiga, Sophie
Derrien, Jennifer
Thirouard, Laura
Bouard, Louise
Asnagli, Helene
Beer, Philip
Parker, Andrew
Gomez-Bougie, Patricia
Devilder, Marie-Claire
Moreau, Philippe
Touzeau, Cyrille
Moreau-Aubry, Agnes
Chiron, David
Pellat-Deceunynck, Catherine
HEMASPHERE, 2024, 8 (10):
[9] Radiosensitization of p53-deficient lung cancer cells
Tokalov, S. V.
Abolmaali, N. D.
EUROPEAN JOURNAL OF CELL BIOLOGY, 2010, 89 : 43 - 43
[10] Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolites
Fedier, A
Schlamminger, M
Schwarz, VA
Haller, U
Howell, SB
Fink, D
ANNALS OF ONCOLOGY, 2003, 14 (06) : 938 - 945

← 1 2 3 4 5 →